USX:MYNZ - Mainz Biomed NV Mainz Biomed BV
Sector: Health Care, Industry: Life Sciences Tools & Services
Next Earnings: 13 May 2024
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 0.904    -0.027 (-2.92%)

18 Apr 2024


Loading...
Loading...
Loading...

General

CEO: Mr. Guido Baechler

IPO: 2021-11-05

Headquarters: US

Employees: 58

Homepage

Description

Mainz Biomed NV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. Its main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.

Your Holdings
Dashboard
Portfolio
Options

Tools
Screener
Watchlist
Alerts
Notes
Community
Forum
Blog
YouTube
Shared Portfolios
Shared Screeners

Collab with Brokerages
Moomoo x StocksCafe
Tiger x StocksCafe

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
Singapore T-Bills
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
YouTube
Server T4

About · FAQs · StocksCafe © 2024 · Privacy · Terms